What does DR. SABINE VERGAUWEN do?

DR. SABINE VERGAUWEN is a healthcare practice in Bornem. Private Limited, started on 15 January 2001.

What is the address of DR. SABINE VERGAUWEN?

The registered office of DR. SABINE VERGAUWEN is located at Victor De Witstraat(HIN) 37 box A, 2880 Bornem.

Is DR. SABINE VERGAUWEN still active?

Yes. According to the CBE (2 November 2026) DR. SABINE VERGAUWEN is active, legal situation “Normale toestand”, started on 15 January 2001.

Is DR. SABINE VERGAUWEN registered on Peppol?

Yes, DR. SABINE VERGAUWEN is registered on the Peppol network with ID 0208:0473819066.

What is the enterprise number of DR. SABINE VERGAUWEN?

The enterprise number of DR. SABINE VERGAUWEN is BE0473819066.

When was DR. SABINE VERGAUWEN founded?

DR. SABINE VERGAUWEN was founded on 15 January 2001.

Who are the directors of DR. SABINE VERGAUWEN?

According to the 2025 annual accounts, the directors of DR. SABINE VERGAUWEN are: Sabine Vergauwen.

Is DR. SABINE VERGAUWEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 January 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. SABINE VERGAUWEN make in 2025?

DR. SABINE VERGAUWEN posted a profit after taxes of € 250,405 in financial year 2025.

What is the revenue of DR. SABINE VERGAUWEN?

As a small company, DR. SABINE VERGAUWEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 352,514.

DR. SABINE VERGAUWEN (Private Limited) - Bornem

Dossier DR. SABINE VERGAUWEN, printed on 3 November 2026 from databakkes.be/en/0473819066/dr-sabine-vergauwen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. SABINE VERGAUWEN from Bornem, company number BE0473819066, closed financial year 2025 with a result of € 250,405 after tax. For that financial year DR. SABINE VERGAUWEN recorded a gross margin of € 352,514 and equity of € 2 million. Compared with financial year 2024, the result moved from € 249,009 to € 250,405. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Growing

€ 2 million

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 250,405

▲ 1% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 949,320

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 78,873 paid out

31 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 49

▲ 8% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 55,080

▲ 100% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 281,963 Gross margin 2022: € 281,963 First fiscal year in the series	€ 314,968 Gross margin 2023: € 314,968 ▲ 12% vs 2022 (€ 281,963) Favourable step	€ 347,739 Gross margin 2024: € 347,739 ▲ 10% vs 2023 (€ 314,968) Favourable step	€ 352,514 Gross margin 2025: € 352,514 ▲ 1% vs 2024 (€ 347,739) Favourable step	▲ 1%
Profit after taxes	€ 189,189 Profit after taxes 2022: € 189,189 First fiscal year in the series	€ 221,105 Profit after taxes 2023: € 221,105 ▲ 17% vs 2022 (€ 189,189) Favourable step	€ 249,009 Profit after taxes 2024: € 249,009 ▲ 13% vs 2023 (€ 221,105) Favourable step	€ 250,405 Profit after taxes 2025: € 250,405 ▲ 1% vs 2024 (€ 249,009) Favourable step	▲ 1%
Equity	€ 1,398,160 Equity 2022: € 1,398,160 First fiscal year in the series	€ 1,619,265 Equity 2023: € 1,619,265 ▲ 16% vs 2022 (€ 1,398,160) Favourable step	€ 1,868,275 Equity 2024: € 1,868,275 ▲ 15% vs 2023 (€ 1,619,265) Favourable step	€ 2,039,806 Equity 2025: € 2,039,806 ▲ 9% vs 2024 (€ 1,868,275) Favourable step	▲ 9%
Total debts	€ 37,768 Total debts 2022: € 37,768 First fiscal year in the series	€ 29,542 Total debts 2023: € 29,542 ▼ 22% vs 2022 (€ 37,768) Favourable step	€ 34,171 Total debts 2024: € 34,171 ▲ 16% vs 2023 (€ 29,542) Unfavourable step	€ 135,262 Total debts 2025: € 135,262 ▲ 296% vs 2024 (€ 34,171) Unfavourable step	▲ 296%
Cash	€ 1,116,870 Cash 2022: € 1,116,870 First fiscal year in the series	€ 853,065 Cash 2023: € 853,065 ▼ 24% vs 2022 (€ 1,116,870) Unfavourable step	€ 1,177,857 Cash 2024: € 1,177,857 ▲ 38% vs 2023 (€ 853,065) Favourable step	€ 949,320 Cash 2025: € 949,320 ▼ 19% vs 2024 (€ 1,177,857) Unfavourable step	▼ 19%
Retained profit	€ 1,385,760 Retained profit 2022: € 1,385,760 First fiscal year in the series	€ 1,606,865 Retained profit 2023: € 1,606,865 ▲ 16% vs 2022 (€ 1,385,760) Favourable step	€ 1,855,875 Retained profit 2024: € 1,855,875 ▲ 15% vs 2023 (€ 1,606,865) Favourable step	€ 2,027,406 Retained profit 2025: € 2,027,406 ▲ 9% vs 2024 (€ 1,855,875) Favourable step	▲ 9%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 78,873 Dividend 2025: € 78,873 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,435,928 Balance sheet total 2022: € 1,435,928 First fiscal year in the series	€ 1,648,807 Balance sheet total 2023: € 1,648,807 ▲ 15% vs 2022 (€ 1,435,928) Unchanged	€ 1,902,446 Balance sheet total 2024: € 1,902,446 ▲ 15% vs 2023 (€ 1,648,807) Unchanged	€ 2,175,068 Balance sheet total 2025: € 2,175,068 ▲ 14% vs 2024 (€ 1,902,446) Unchanged	▲ 14%

Key figures of DR. SABINE VERGAUWEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. SABINE VERGAUWEN?

What happened at DR. SABINE VERGAUWEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 250,405 (▲ 1% vs 2024). Source: NBB ↗
Jan 15, 2001 Start of the company according to the CBE. KBO

In short

From € 189,189 profit in 2022 to € 250,405 profit in 2025.

Paid € 413,426 in corporate taxes since 2022.

Best year ever: 2025, with € 250,405 profit.

Paid out € 78,873 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Sabine Vergauwen

DR. SABINE VERGAUWEN

Behind DR. SABINE VERGAUWEN is Sabine Vergauwen.

Directors

According to the 2025 annual accounts

Sabine Vergauwen

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Victor De Witstraat(HIN) 37 box A

2880 Bornem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0473.819.066

VAT number

BE 0473.819.066

Registered office

Victor De Witstraat(HIN) 37 bus A, 2880 Bornem

Names & denominations

DR. SABINE VERGAUWEN

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 January 2001

Peppol

Active · Active since 29 Dec 2024

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. SABINE VERGAUWEN

Financials

What happened to DR. SABINE VERGAUWEN?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions